Key Metrics
CiteScore 

4.6
H-Index 

52
Impact Factor 

< 5
SJR 

Q2Pharmacology

SNIP 

0.87
Recommended pre-submission checks
Powered by 

Topics Covered on Cardiovascular Therapeutics
Cardiovascular Therapeutics Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | WILEY-HINDAWI |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2000 |
| Publication Time | 19 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in Cardiovascular Therapeutics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Cardiovascular Therapeutics
Correlation Between Apolipoprotein B and Severity of Coronary Artery Stenosis in Individuals Aged 45 and Above: A Cross\u2010Sectional Study
- 5 Aug 2026
- Cardiovascular Therapeutics
Analysis of the Correlation Between Helper T\u2010Lymphocyte Subsets and Atrial Fibrillation: An Observational and Mendelian Randomization Study
- 4 Aug 2026
- Cardiovascular Therapeutics
The Prognostic Value of Different Patterns of Neoatherosclerosis and Treatment Modality in Patients With Coronary In\u2010Stent Restenosis
- 17 Jun 2026
- Cardiovascular Therapeutics
Baseline Ejection Fraction as a Modifier of Beta\u2010Blocker Therapeutic Effects in Post\u2010Acute Coronary Syndrome Patients With Non\u2010Reduced Ejection Fraction: A Systematic Review and Meta\u2010Analysis
- 17 Jun 2026
- Cardiovascular Therapeutics
Exploring the Other Side of Medication: A Patient Interview Study on Anti\u2010PCSK9 Monoclonal Antibodies
- 16 Jun 2026
- Cardiovascular Therapeutics
Lycorine Attenuates Cardiac Fibrosis Through the Regulation of PYK2 Expression and Activity
- 16 Jun 2026
- Cardiovascular Therapeutics
Correlation Between Apolipoprotein B and Severity of Coronary Artery Stenosis in Individuals Aged 45 and Above: A Cross\u2010Sectional Study
- 5 Aug 2026
- Cardiovascular Therapeutics
Analysis of the Correlation Between Helper T\u2010Lymphocyte Subsets and Atrial Fibrillation: An Observational and Mendelian Randomization Study
- 4 Aug 2026
- Cardiovascular Therapeutics
The Prognostic Value of Different Patterns of Neoatherosclerosis and Treatment Modality in Patients With Coronary In\u2010Stent Restenosis
- 17 Jun 2026
- Cardiovascular Therapeutics
Baseline Ejection Fraction as a Modifier of Beta\u2010Blocker Therapeutic Effects in Post\u2010Acute Coronary Syndrome Patients With Non\u2010Reduced Ejection Fraction: A Systematic Review and Meta\u2010Analysis
- 17 Jun 2026
- Cardiovascular Therapeutics
Exploring the Other Side of Medication: A Patient Interview Study on Anti\u2010PCSK9 Monoclonal Antibodies
- 16 Jun 2026
- Cardiovascular Therapeutics
Lycorine Attenuates Cardiac Fibrosis Through the Regulation of PYK2 Expression and Activity
- 16 Jun 2026
- Cardiovascular Therapeutics